According to recently conducted experiments, cannabis can be thought to be a good treatment for patients diagnosed with multiple sclerosis. While in the beginning the symptomatic improvements experienced by patients with multiple sclerosis who have been administered cannabinoid products were viewed as determined entirely by mental factors, eventually reports have shown that cannabis actually reduces muscular stiffness and spasms characteristic to multiple sclerosis sufferers. The benefic effects of cannabis on patients with multiple sclerosis were established by short-term and long-term controlled medical studies.
In 2003, a team of researchers from the Peninsula Medical School in Exeter, UK usually make public the results of a number of short-term and long-term studies on the effects of cannabinoids among patients with multiple sclerosis. The previously conducted research involved the active participation of around 600 individuals with advanced stage multiple sclerosis. The people had been divided in two distinctive groups: the very first group was given cannabinoid substances in equal doses, while the next group received placebo medications with a period of fifteen weeks. By the conclusion of the test, the majority of patients that happened to be administered cannabinoids felt considerable symptomatic improvements, having less muscular pain and being confronted with gentler muscular spasticity (less pronounced muscular spasm). Unlike the team which was given cannabinoid compounds over the whole time of the study, the management group (patients that received placebo medications) skilled no advancements in their overall condition.
In order to establish the relevancy of the results also to discard some concerns concerning the efficiency of cannabis within ameliorating the symptoms of multiple sclerosis, the analysis was later repeated. The ulterior analysis was carried out over a period of twelve weeks, and involved the participation of the exact same subject matter. Nonetheless, this time the participants were divided into three distinct groups instead of 2 as in the circumstances of the preceding experiment. The earliest group received pills of D9-tetrahydrocannabinol (THC) - the active component in cannabis, the second group received natural cannabis extracts, while the 3rd group received placebo medications.
At the end of the test, condor reviews (https://healdi.co.kr/bbs/board.php?bo_table=free&wr_id=11937) individuals had been meticulously examined and examined by a team of neurologists and physiotherapists. The best results were obtained among the individuals belonging to the original study group, the majority of subjects that received equal doses of THC encountering considerable improvements in the symptoms of theirs. The patients in the second study group encountered slight changes in their symptoms, even though the patients in the third group sensed no changes in their condition.
Despite the fact these studies clearly claim that cannabis is a good remedy for multiple sclerosis, medical researchers are not still convinced that cannabinoids can be successfully used in the treatment of several sclerosis. But, after performing more studies on the issue and much more elaborate research, doctors is possible to consider introducing cannabinoid compounds in the treatment of several sclerosis in the near future.